LAB ONE LLC NPI 1639417140

NPI Details

LAB ONE LLC is a clinical medical laboratory in Fairfield, IL. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. LAB ONE LLC NPI is 1639417140. The provider is registered as an organization entity type.
The provider Is Doing Business As Quest Diagnostics.

The provider's business location address is:

209 NW 11TH ST
FAIRFIELD, IL
ZIP 62837-218
Phone: (618) 842-4470

The provider's authorized official is Charles Albert Bowles .
The authorized official title is Vice President and has the following contact phone number (610) 454-6000.

The CLIA number assigned to this NPI record is 14D2044263 - independent with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Pap test, manual screening (HCPCS:88142)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)

The enumeration date for this NPI number is 1/18/2013 and was last updated on 12/11/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: